Cost of Parkinson's Disease in Hong Kong

NCT05774210 | Unknown DMC

• 1 other identifier: HMRF_SW_2023
• Study Type: observational
• Target: 139
• Locations: 0 countries
• Sites: N/A

Brief Summary

The goal of this study is to estimate the cost of disease and falls among people with Parkinson's disease in Hong Kong . There will be no intervention delivered to the participants. The healthcare cost of 12 months will be recorded using self-report and and the Hospital Authority Clinical Management System.

Conditions

Parkinson Disease

Keywords

Cost of illness; Falls; PD; Disease burden

Outcome Measures

Primary Outcomes (1)

• Client Service Receipt Inventory - RAre disease (CSRI-Ra)

  The CSRI is a widely used measure for recording cost-related data. The measure covers five key sections including background information, household and carer support, healthcare service and resource utilization, community support and education and employment. The CSRI-Ra is cross-culturally validated for Hong Kong Population (reference added to appendix 3a). The Chinese version of the self-reported CSRI-Ra both the patient version and carers version will be used in this study. The cost data will be captured across 6 months retrospective period. The background section 1 will be completed during the baseline assessment (T1) and sections 2 onwards will be completed during T2 and repeated during T3 assessment timelines.

  Change score after 6 months and 12 months

Secondary Outcomes (6)

• Number of falls

  Change score after 6 months and 12 months

• The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

  Change score after 6 months and 12 months

• Hoehn and Yahr Scale

  Change score after 6 months and 12 months

• Falls Efficacy Scale-International (FES-I)

  Change score after 6 months and 12 months

• Activities-Specific Balance Confidence Scale (ABC)

  Change score after 6 months and 12 months

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Community-dwelling patients with a confirmed diagnosis of Parkinson's disease who attend the outpatient clinics of the Prince Wales Hospital, Shatin and Queen Mary Hospital, Pok Fu Lam will be included in this study.

You may qualify if:

• Community-dwelling participants with a confirmed diagnosis of Parkinson's disease Reside in Hong Kong

You may not qualify if:

• Patients who are bedridden or solely wheelchair users, Have atypical Parkinson's syndrome and Have other associated major illnesses, such as stroke.

Sponsors & Collaborators

• The Hong Kong Polytechnic University: lead
• Chinese University of Hong Kong: collaborator
• The University of Hong Kong: collaborator

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases

Study Officials

• Stanley J Winser, PhD

  The Hong Kong Polytechnic University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Stanley J Winser, PhD

CONTACT

27666746; stanley.j.winser@polyu.edu.hk

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 12 Months
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 7, 2023
• First Posted: March 17, 2023
• Study Start: May 1, 2023
• Primary Completion: May 1, 2025
• Study Completion: July 1, 2025
• Last Updated: March 17, 2023

Record last verified: 2023-02